The federal government is the single biggest source for the primary research that leads to new vaccines.
But, like the pharmaceutical industry, it currently is not supporting a valley fever vaccine. Other diseases that affect far fewer people receive much more federal support.
Tularemia only affects about 200 people in the country annually, less than 1 percent of the estimated 150,000 people hit by valley fever. Like valley fever, the disease is primarily concentrated in only a portion of the country, mostly in the south-central and western part of the country.